CareDx Inc. (1K9)
Munich
Closed
Aug 26, 2026
Day's Range
43.4052 wk Range
10.95Overview - 1K9 - CareDx Inc.
Key Statistics
Valuation
Enterprise Value
-39.23M
P/E (Trailing)
‪-108.50‬
PEG Ratio
‪0.07‬
Price / Book
‪5.24‬
EV / EBITDA
‪-37.18‬
Profitability
Gross Margin
‪73.50%‬
Profit Margin
‪67.55%‬
Operating Margin
‪-6.60%‬
Return on Assets
‪-5.16%‬
Return on Equity
‪-7.04%‬
Ownership
Shares Outstanding
51.48M
Price stats
50-Day Avg
‪30.78‬
200-Day Avg
‪20.17‬
Peers - 1K9 - CareDx Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on Munich.
- 1K9MunichCareDx Inc.+73.84%52-week change-99.00P/E (Trailing)‪67.55%‬Profit Margin
- 45EMunichNATERA INC (Common Stock) – ticker 45E+55.09%52-week change-125.99P/E (Trailing)‪-9.04%‬Profit Margin
- 1HMMunichAdaptive Biotechnologies Corporation+50.16%52-week change-56.23P/E (Trailing)‪-20.72%‬Profit Margin
- 0MEMunichTwist Bioscience Corporation+80.48%52-week change-93.58P/E (Trailing)‪50.72%‬Profit Margin
- 04XMunichPersonalis Inc.+72.42%52-week change-16.38P/E (Trailing)‪22.65%‬Profit Margin
- 5GHMunichGuardant Health Inc.+61.55%52-week change-42.58P/E (Trailing)‪64.46%‬Profit Margin
- NG9MunichNeoGenomics Inc.+59.90%52-week change-16.92P/E (Trailing)‪43.21%‬Profit Margin
Profile Summary - 1K9 - CareDx Inc.
About
CareDx Inc. is a leading precision medicine company that discovers, develops, and commercializes clinically differentiated diagnostic solutions for transplant patients and caregivers. It specializes in genomics-based testing services, including AlloSure Kidney and AlloSure Heart for donor-derived cell-free DNA…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
